Stocks
Exact Sciences CorporationEXAS
NASDAQHealthcareDiagnostics & Research$103.57+0.29%
A molecular diagnostics company focused on cancer screening and precision oncology testing, best known for its stool-based colorectal cancer screening test, Cologuard. The firm develops and commercializes tests that use DNA and other biomarkers to detect cancer and guide treatment decisions. Investo...
Market Cap: $19.8B52W Range: $38.81 – $103.75
Congressional Interest in Exact Sciences Corporation (EXAS)
7 members of Congress have disclosed 34 trades in Exact Sciences Corporation (EXAS), a Healthcare company. The buy/sell breakdown shows 16 purchases versus 18 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
34
Unique Politicians
7
Buys
16
Sells
18
Who in Congress Is Trading EXAS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-24 | Kevin Hern | sell | $1K – $15K |
| 2024-05-10 | Josh Gottheimer | sell | $1K – $15K |